Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.
Lam, P.Y., Jadhav, P.K., Eyermann, C.J., Hodge, C.N., Ru, Y., Bacheler, L.T., Meek, J.L., Otto, M.J., Rayner, M.M., Wong, Y.N., Chang, C.-H., Weber, P., Jackson, D.A., Sharpe, T.R., Erickson-Viitanen, S.(1994) Science 263: 380-384
- PubMed: 8278812 
- DOI: 10.1126/science.8278812
- Primary Citation of Related Structures:  
1HVR - PubMed Abstract: 
Mechanistic information and structure-based design methods have been used to design a series of nonpeptide cyclic ureas that are potent inhibitors of human immunodeficiency virus (HIV) protease and HIV replication. A fundamental feature of these inhibitors is the cyclic urea carbonyl oxygen that mimics the hydrogen-bonding features of a key structural water molecule ...